<DOC>
	<DOCNO>NCT02825251</DOCNO>
	<brief_summary>This trial conduct Europe United States America ( USA ) . The aim trial investigate efficacy safety Continuous Subcutaneous Insulin Infusion Faster-acting Insulin Aspart compare NovoRapid® Adults Type 1 Diabetes .</brief_summary>
	<brief_title>Efficacy Safety Continuous Subcutaneous Insulin Infusion Faster-acting Insulin Aspart Compared NovoRapid® Adults With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Male female , age least 18 year time signing informed consent Diagnosed T1DM ( Type 1 Diabetes Mellitus ) ( base clinical judgement and/or support laboratory analysis per local guideline ) equal 1 year prior day screen Using Medtronic pump ( Minimed 530G ( 551/751 ) , Paradigm Veo ( 554/754 ) , Paradigm Revel ( 523/723 ) , Paradigm ( 522/722 ) ) CSII basalbolus regimen rapid act insulin analogue least six month prior screen willing stay pump model throughout trial ( model change change exceed 7 consecutive day . ) HbA1c ( glycosylated haemoglobin ) 7.09.0 % ( 5375 mmol/mol ) assess central laboratory screen Body mass index ( BMI ) equal 35.0 kg/m^2 screen Ability willingness take least 3 daily mealtime insulin bolus infusion every day throughout trial Any following : myocardial infarction , stroke , hospitalization unstable angina transient ischaemic attack within past 180 day prior day screen Planned coronary , carotid peripheral artery revascularisation know day screen History hospitalization ketoacidosis equal 180 day prior day screen Treatment medication indication diabetes obesity state inclusion criterion period 90 day screen Any condition , opinion Investigator , might jeopardise Subject 's safety compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>